Content labelled as: Research

Low-dose Naltrexone Changes Levels of Inflammatory Proteins in MS, Study Shows

Blog post

Source Multiple Sclerosis News Today:

Inhibition of the neuroactive opioid growth factor (OGF) alters the blood levels of important pro- and anti-inflammatory proteins in mice with multiple sclerosis (MS)-like disease.

A £10 gesture of thanks offered to MS participants who complete survey

Blog post

Opinion Health is currently conducting a study that involves patients with multiple sclerosis, and we would like to kindly ask for your support.

Men hold secret to protect women from multiple sclerosis

Blog post

Source EurekAlert:

Guardian molecule induced by testosterone reverses harmful immune response, eliminates disease symptoms in female mice.

NICE proposes rejecting five drugs for relapsing MS - MS Trust responds

Blog post

Source MS Trust:

NICE has recommended Extavia, but rejected Copaxone, Avonex, Betaferon, Plegridy and Rebif in its preliminary appraisal of MS drugs. The MS Trust has responded to NICE’s consultation in the strongest possible terms.

Ocrelizumab licensed for people with early primary progressive MS in the UK

Blog post

Source MS Society:

Ocrelizumab has been approved as the first licensed treatment for some people with primary progressive MS in the UK.

The Search for a Miracle Cure - Channel 4, 23rd November at 10pm

Blog post

Source Radio Times:

Documentary following leading lawyer Mark Lewis, the man who fought the News of the World in the phone hacking scandal, as he joins a clinical trial that might offer a breakthrough cure for multiple sclerosis. He learned he had the condition at the age of 25 but his...

Cannabinoid, Dronabinol, Seen as Long-term Treatment Option for Neuropathic Pain in Phase 3 Study

Blog post

Source Multiple Sclerosis News Today:

Multiple sclerosis (MS) patients being treated with dronabinol, a cannabinoid, do not show signs of drug abuse or dependency, leading researchers to conclude it has potential to be a long-term and safe treatment option for neuropathic pain.

Ozanimod Superior to Avonex in Treating Relapsing MS in Phase 3 Trials, Celgene Reports

Blog post

Source Multiple Sclerosis News Today:

Celgene released the results of two Phase 3 trials showing that patients with relapsing multiple sclerosis (MS) who were treated with ozanimod had lower relapse rates and fewer MRI brain lesions compared to those given a current first-line therapy,...

The MS Society explore 5 myths about cannabis and MS

Blog post

Source MS Society:

There’s mounting evidence to show that cannabis could help pain and muscle spasms for people with MS. But with tonnes of information swirling around the internet, it’s hard to be sure what’s true and what’s not.

We dived into the details to bust 5 common myths...

Diagnostic Blood Test May Be Able to Distinguish Between RRMS and PPMS, Researchers Say

Blog post

Source Mutiple Sclerosis News Today:

In the future, a blood test may make diagnosing multiple sclerosis (MS) much easier, thanks to newly identified biomarker patterns that distinguish between MS patients and healthy people.

Pages

Subscribe to Content labelled as: Research